News

Svenska

The power of collaboration

In June 2020 Clara Hellner was appointed Director of Research and Innovation for Region Stockholm. We had the opportunity to ask a few questions about her visions for research and innovation in general and during the pandemic in particular.

2021-02-19

The triple helix model is appealing to many countries

Business Sweden guides Swedish companies to increased global sales, and assists international companies to invest and grow in Sweden. We got the opportunity to ask Claudia Hidou, Swedish Industry and Healthcare Advisor at Business Sweden, a few questions related to the health and life science sector.

2021-02-18

Webinar online: Post-pandemic opportunities for life science financing

How has the pandemic affected the growth potential and what are the future prospects of the life science industry? Learn more about the view of life science professionals and investors. Will we experience a post-pandemic shift of focus for public innovation funding?

2021-02-02

Synthesized health data for better care

Johanna Brinne Roos works at the Center for Health Data, a part of Region Stockholm. She is currently investigating the legal requirements for care and health data to be used by researchers without compromising patient integrity. We asked a few question about the mission.

2021-01-29

Stockholm Life Tech makes the regions honey magnets visible for SME:s

The Stockholm Life Tech project aims to make research and innovation infrastructures available to small and medium-sized companies. The project is funded by the European Regional Development Fund with Stockholm Region as project owner. Partners are Akademiska Hus, Flemingsberg Science, Karolinska Institutet, Karolinska Institutet Science Park, Karolinska University Hospital and Stockholm Science City. We had the opportunity to ask a couple of questions to project manager Nina Lahti who has worked on the project since the start in the early summer of 2020.

2021-01-28

The life science industry view on post-pandemic growth

Martina Banyay and Åsa Angel Voss are Growth Partners at the company One in 200 - a newly started consulting company that supports life science companies in their growth initiatives. They are also co-authors of the report Growth in the new normal, which is based on interviews with 25 Swedish life science companies about how their operations have been affected by the pandemic and how growth in the "new normal" is viewed. On February 2, they tell more during the webinar "Post-pandemic opportunities for life science financing".

2021-01-27

CHaSE - Stockholm's premier career and jobs fair

CHaSE (Careers in Health and Science Exposition) was founded 2014 by a Karolinska Institutet (KI) student initiative and is organized by KI’s medical student association, Medicinska Föreningen. Since then it has been a unique, annual career and jobs fair within the healthcare and life science sector. It serves as a platform both to students, to plan their post-university career, as well as for companies to seek highly qualified employees from all Swedish universities. CHaSE aims to be very interactive and therefore the day is comprised of interesting company presentations, dynamic workshops, and professional networking events.

2021-01-25

Molecular Attraction appealed the jury of Stockholm Innovation Scholarship

With the Stockholm Innovation Scholarship, the City of Stockholm wants to ”reward creative people with bright ideas and encourage them to further develop their ideas”. The scholarship has been awarded since 1985. This years winner in the category of Life science and health is Molecular Attraction. We got the opportunity to ask Johan Paleovrachas, co-founder and chairman of the board, a few questions.

2020-12-17

Covid-19 efforts in the region: November/December update

The last update for the year on Covid-19 efforts in the region from Stockholm Science City. Since March, we have compiled examples of efforts and collaborations between universities, industry, and health care focusing on the SARS-CoV-2 virus and Covid-19.

2020-12-17

Season’s Greetings from Stockholm Science City

2020 will be remembered as the year when research and the general public hooked arm, and side by side battled an invisible enemy. The year when science in a very short time made it possible to develop an effective weapon to force this opponent back.

2020-12-11

A blueprint on good off-label use practice

Frédéric Destrebecq is Executive Director of the European Brain Council (EBC), platform for patients, health professionals, scientists & industry that promotes brain research in Europe with the aim of improved quality of life for patients. As part of that mission, he advocates for the need to implement a uniform approach for off-label prescription at European level. We had the opportunity to ask a few questions.

2020-12-10

Online panel discussion: Future of Health: Mental health

How are you - really? Alarms about rapidly increasing issues related to mental health are common and new national and regional strategies to address the problems are being developed. Today, almost half of all sick leave is based on a psychiatric diagnosis, which can be compared with just under a fifth 20 years ago. During 2018, antidepressant drugs were prescribed to one out of ten Swedes. At the same time, studies show that self-estimated well-being are on a level that has not changed significantly over time. Below, you can watch the panel discussion on various aspects of mental health, which was held on December 10, 2020.